The Impact of Chebulagic Acid on Anti-Cancer Activity Across Different Human Cancer Cell Lines

This review aims to explore the potential of Chebulagic acid, a hydrolysable tannin derived from
Terminalia chebula, in the treatment of cancer. Chebulagic acid boasts a myriad of medicinal and
pharmacological benefits, including but not limited to antibacterial, antiviral, antioxidant,
antidiabetic, antifungal, antiulcer, anticancer, antimutagenic, and wound healing properties. The
objective of this review is to compile existing scientific literature on the anticancer attributes of
Chebulagic acid. Numerous studies have elucidated its ability to regulate apoptosis and inhibit
proliferation in various cancer cell lines and pathways. Nonetheless, further in vivo investigations are
imperative to thoroughly dissect the mechanism-based pharmacological profile of Chebulagic acid.
Such studies will furnish robust scientific evidence elucidating its anticancer efficacy across different
cancer types and appraise its suitability for clinical trials.